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The coronavirus disease 2019 (COVID-19) pandemic has upended health systems all over the 
world and clinical pharmacy has not been spared from this disruption. In some situations, this 
has meant an expansion of duties and provision of additional funding to support this.(1, 2) In 
others, it has led to a clear designation of which health services are deemed to be essential and 
which are expendable. So far, governments worldwide have rightly deemed physical access to 
medications to be crucial. And in most countries, pharmacists are still the main gatekeepers and 
suppliers of medicines.  
The COVID-19 pandemic, however, has seen a tremendous acceleration of technologies which 
have automated and digitized many aspects of the medication supply chain. For example, 
telehealth initiatives in Australia that were previously planned to take a decade have been 
implemented almost overnight.(3) As vulnerable patients, especially those with chronic 
diseases, immunosuppression, and the elderly, are being encouraged to continue physical 
distancing measures likely for the next few years, it will not be surprising to see that many 
patients prefer the ease and perceived safety of medication delivery services (e.g., Amazon 
Pillpak, drone deliveries) as opposed to the risk of further exposure when meeting in person 
with a pharmacist.(4, 5)  It is not difficult to see how the proximity to a product, the role the 
public most closely associates with pharmacists, will change. And because many of the clinical 
services that pharmacists provide are bundled with medicine access, we have limited time to 
confirm our role as essential in the modern health care team.  
Bauman suggests that “... physicians know, nurses know, and respiratory therapists know —
about [pharmacists] and what we do and what value we provide to them and their/our 
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patients.”(6) We suggest that while this may be true in academic health centers in the United 
States, this model does not represent the majority of care settings and communities worldwide. 
Bauman further acknowledges that even when other health care providers champion 
pharmacists as valuable team members, “this knowledge has apparently not always been 
translated to the public, the news media, and politicians.”(6) This statement stops short of a call 
to action but surely indicates that in a time of great uncertainty in the world, the often 
“overlooked” patient-centered roles of pharmacists are endangered. Indeed, the overwhelming 
emphasis remains on the most visible tasks of pharmacists; simply ensuring that patients have 
access to medical products without providing counseling and other patient care services that 
should be at the heart of every pharmacy encounter. This risk of obsolescence is amplified by 
our demography. Bauman also highlights that clinical pharmacy globally is relatively new, 
relatively small, and suffers from complicated nomenclature when compared with doctors and 
nurses.(6) For a profession that prides itself on translating evidence into practice, we are also 
relatively slow in widely disseminating our proven public health initiatives and their impact. For 
example, despite evidence which suggests that 10 million lives per year could be saved by 
increasing access to vaccination, the inclusion of pharmacist providers in national vaccination 
policies has developed very gradually within and across countries.(7) As the push for a COVID-
19 vaccine becomes a top priority, the capacity to manufacture and administer this vaccine may 
be hampered by the lack of pharmacists who are specifically trained for, permitted to perform, 
and allowed to be compensated for these services.   
The American College of Clinical Pharmacy (ACCP) has previously described tasks common to 
clinical pharmacists in the U.S.(8) Gross and MacDougall have refined these tasks in the 
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context of the COVID-19 pandemic.(9) Via this editorial, we offer a more international 
perspective. Figure 1 outlines ways clinical pharmacists can support the current acute need that 
will also amplify the value for a new normal.  While the descriptions in Figure 1 represent broad 
generalizations of the international practice of pharmacy during the COVID-19 pandemic, our 
intention is not to dismiss the many pharmacy providers who are going the extra mile to 
preserve their clinical responsibilities for patients.(1, 6, 10) Our intention, instead, is to spark a 
call for action compelling our entire profession to make that level of practice the base 
expectation for all patients. As the prolonged COVID-19 pandemic and its associated 
restrictions continue to push us to develop additional strategies to preserve the medical supply 
chain, we anticipate that considerations for clinical pharmacy activities will decline.  Instead, we 
need to develop more visible patient-centered strategies that enhance our ability to respond to 
COVID-19-related challenges.  In addition to the tasks listed in Figure 1, we must utilize our 
frequent interactions with patients to address the rampant misinformation spreading across the 
world that frequently spreads during viral epidemics.  This was evident in South Africa during 
the human immunodeficiency virus (HIV) epidemic as their pollical leadership denied access to 
proven antiretrovirals for the prevention of mother-to-child transmission, and more recently 
when political leaders from the U.S. touted unproven treatments for COVID-19 which lead to 
fatal overdoses and poisonings in other countries like Nigeria.(11-14) 
In order to illustrate pharmacy-based adaptations made in response to COVID-19, we briefly 
highlight two global examples where clinical pharmacy activity was preserved: 
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Trained Students Support Dispensing Activities to Enable Clinical Pharmacy Roles to Continue 
in the Wards in Australia 
In Australia, as the pandemic worsened globally, the key health settings (hospitals and 
community pharmacies) struggled to project how they would optimize care provision while also 
serving as a good learning environment for pharmacy students and pre-registration interns. In 
watching experiential placements/clinical rotations for many health professional students being 
cancelled, there were early discussions about removing all pharmacy trainees from experiential 
sites.(15) Before taking action, however, the local pharmacy academic community held robust 
discussions with practice leaders in medicine, nursing, and pharmacy. When medicine and 
nursing students were retained at their sites, the pharmacy community was concerned that if 
pharmacy students were sent home, this would imply they could not contribute. Thus, the 
pharmacy community agreed to similar approaches as our medicine and nursing colleagues 
(e.g., adopting protective modalities, adjusting which services hosted students, and revising the 
specific activities to be completed) for ensuring safe and supported learning environments. In 
addition, many hospital sites suggested that by having skilled pharmacy students rotating 
through to support medication provision meant that more experienced pharmacists could remain 
allocated to direct patient care services. Further, when didactic instruction was converted to 
online teaching, many community pharmacy sites supplemented their “surge workforce” with 
additional pharmacy students. The Council of Pharmacy Schools: Australia and New Zealand, 
composed of the heads of the pharmacy programs in these countries, developed guiding 
principles for pharmacy student clinical education during a global health emergency to support 
the pandemic workforce as part of and in parallel to academic studies.(16) The health care 
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community responded positively, publicly noting the contributions of pharmacy students.(17) 
Although programs allowed those who were especially anxious to defer their placements, most 
students chose to continue and described positive learning experiences while supporting a 
critical need.(18) 
 
Creative Solutions to Clinical Pharmacy Barriers in Malaysia 
In Malaysia, clinically ill patients suspected or confirmed to have COVID-19 are admitted into 
the hospital and kept there until they are cured or repeatedly test negative for COVID-19. As 
such, there has been a push to ensure that all non-essential staff are kept out of the wards to 
reduce the risk of being infected with COVID-19. Unfortunately, in many hospitals, clinical 
pharmacists working in the wards have fallen into the “non-essential” category. 
 
As a result, many of these clinical pharmacists have been reassigned by hospital leaders and 
chief pharmacists to support the core function of the pharmacy department, namely the 
continued procurement and supply of medicines and equipment to the rest of the hospital. It is 
disheartening to note that despite the considerable emphasis on the importance of having 
pharmacists provide pharmaceutical care, it is considered at best to be “optional”, and rarely 
“essential”. 
 
It is, however, difficult to stop a pharmacist from providing pharmaceutical care. Despite being 
ordered out of the wards and asked to focus on the supply chain, many clinical pharmacists 
have found ways to continue contributing to patient care and the quality use of medicines. 
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Through collaborative discussions with other members of the health care team, clinical 
pharmacists in Malaysia have been able to continue providing care through the following 
approaches which seek to optimize service delivery while minimizing the spread of COVID-19: 
• Remote screening of medication charts to identify medication-related problems and 
phone calls/text messaging to prescribers to address these problems 
• Arranging for short video calls or teleconferences after physicians complete their rounds 
to get updates on the clinical status of select patients in the ward 
• Filming videos of themselves giving instructions on how to use medical devices so that 
nurses can show these videos to patients, in lieu of pharmacist counselling 
• Providing round-the-clock drug information services via phone/email to the physicians 
they usually work with 
• Providing updates on the latest evidence to guide COVID-19 management to other 
members of the health care team.(9)  
 
By continuing to find ways to provide services to patients and the health care team despite 
unfavorable designations by hospital administrators, clinical pharmacists have been able to 
demonstrate their value to the health care system and drive additional demand for their 
services. While pharmacists cannot always directly control the policies which govern our 
practice, no one can control the creativity of pharmacists in finding innovative ways to work 
around these restrictions to optimize care for the patients they serve.   
 
Conclusion 
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Numerous articles have highlighted the role of clinical pharmacy in response to unique COVID-
19-related challenges and the need for greater political advocacy for the value of these 
services.(1, 19)  While we agree with the importance of political advocacy, there is an even 
more pressing need to align pharmacist services visibly with the needs of the community.  This 
will generate more demand for the impactful services pharmacists could deliver.  But it is how 
we talk about these services – simply, frequently, publicly – that will translate that potential into 
reality.  Advocacy for expanded pharmacy roles, when most of the public does not understand 
why that would be helpful, is a fruitless endeavor.  This has been demonstrated by the 
protracted fight pharmacists around the world face when trying to expand the privileges they are 
able to lawfully perform on behalf of patients.(20)  
 
Until the public’s perception of the role pharmacists play in improving their health (not only 
providing their medicinal products) changes based on their own personal experiences with high 
quality care, general political advocacy is unlikely to have much impact. The reality is that 
resources are stretched in directions which do not include an expansion of pharmacy roles.  
Expanded employment opportunities for pharmacists will be realized if stakeholders believe that 
three key specifics are true: the care delivered by pharmacists has a significant positive impact 
on health care quality and costs; this care is accomplished via a service that is distinct to 
pharmacists and unable to be delivered by another health care provider (or an emerging 
technology) at a lower price point; and the care process of pharmacists that creates value is 
consistently delivered across all settings and situations.(21) If pharmacists around the world 
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commit to public action now, we may be able to “flatten the curve” of the projected number of 
people who contract COVID-19, while also “raising the bar” for the public’s expectations of what 
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